ORION Sante   Report issue

Academic/Hospital Phase 1 Phase 4
Founded: France

Organization Overview

First Clinical Trial
2002
NCT00761371
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Orion Biotechnology Polska Sp. z o.o.